Lessons from the leucovorin shortages between 2009 and 2012 in a medicare advantage population: where do we go from here?

Effect of rivaroxaban versus warfarin on health care costs among nonvalvular atrial fibrillation patients: observations from rivaroxaban users and matched warfarin users. Adv Ther (2015) 0.76

ASHP Guidelines on Managing Drug Product Shortages in Hospitals and Health Systems. Am J Health Syst Pharm (2009) 3.21

Impact of drug shortages on U.S. health systems. Am J Health Syst Pharm (2011) 2.96

National survey on the effect of oncology drug shortages on cancer care. Am J Health Syst Pharm (2013) 1.43

Effects on patient care caused by drug shortages: a survey. J Manag Care Pharm (2013) 1.17

Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancer. J Clin Oncol (1997) 0.92

Is levoleucovorin an alternative to racemic leucovorin? A literature review. Clin Colorectal Cancer (2009) 0.86

Is response-guided therapy being applied in the clinical setting? The hepatitis C example. Am Health Drug Benefits (2015) 0.78